Are drug eluting stents destined to become the standard of care for all patients undergoing percutaneous coronary intervention, or are alternative therapeutic approaches preferable under certain circumstances?
Published in the Heart 2005;91:1377-1379;
Abbreviations: CABG, coronary artery bypass graft surgery; DES, drug eluting stents; MACE, major adverse cardiac events; PCI, percutaneous coronary intervention; TLR, target lesion revascularisation; TVR, target vessel revascularisation
Keywords: drug eluting stents; percutaneous coronary intervention; rapamycin
